Status:
NOT_YET_RECRUITING
Effectiveness of Qualia Magnesium+® Supplementation on RBC Magnesium Levels
Lead Sponsor:
Qualia Life Sciences
Conditions:
Magnesium Deficiency
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
This is a randomized, double-blind, placebo-controlled parallel trial designed to evaluate the effectiveness of Qualia Magnesium+® supplementation on red blood cell (RBC) magnesium levels in adults ag...
Eligibility Criteria
Inclusion
- Provide voluntary, written, informed consent to participate in the study
- Agree to provide a valid cell phone number and are willing to receive communications through text
- Can read and write English
- Willing to complete questionnaires, records, and diaries associated with the study.
- Male and female participants aged 21 years and older
- Willing and able to visit a local blood draw facility for required blood sample collections
- Live within 20 miles of a suitable blood draw facility (such as Quest)
- RBC Magnesium levels below 6.0 mg/dL
- Willing to not consume any supplements containing magnesium starting about 2 weeks prior to the baseline magnesium blood test and continuing through the intervention period.
- Willing to not begin taking any new supplements during the study and continue taking any supplements they are currently using regularly with the exception of those containing magnesium
Exclusion
- Women who are pregnant, breastfeeding, or planning to become pregnant during the trial
- Known food intolerances/allergy to any ingredients in the product
- Having any of the following conditions: Psychiatric conditions, neurologic disorders, endocrine disorders, cancer
- Having had a significant cardiovascular event in the past 6 months
- Taking MAO inhibitors, SSRIs, or any other psychiatric or neurological medicines
- On immunosuppressive therapy
- Individuals who were deemed incompatible with the test protocol
- Adults lacking capacity to consent
Key Trial Info
Start Date :
May 21 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 21 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06979648
Start Date
May 21 2025
End Date
September 21 2025
Last Update
May 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qualia Life Sciences
Carlsbad, California, United States, 92011